Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 4 hours 35 minutes

S&P 500
5,995.61
+26.27(+0.44%)
Dow 30
44,700.83
+404.32(+0.91%)
Nasdaq
19,118.54
+114.89(+0.60%)
Russell 2000
2,464.44
+57.77(+2.40%)
Crude Oil
69.04
-2.20(-3.09%)
Gold
2,633.60
-78.60(-2.90%)

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

93.78

-0.37

(-0.39%)

As of 11:23AM EST. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	5.98B
Enterprise Value	5.72B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	13.48
Price/Book (mrq)	19.10
Enterprise Value/Revenue	13.16
Enterprise Value/EBITDA	-11.22

Trading Information

Stock Price History

Beta (5Y Monthly)	0.59
52-Week Change ³	36.21%
S&P500 52-Week Change ³	31.18%
52 Week High ³	121.90
52 Week Low ³	67.00
50-Day Moving Average ³	90.36
200-Day Moving Average ³	96.10

Share Statistics

Avg Vol (3 month) ³	633.85k
Avg Vol (10 day) ³	616.33k
Shares Outstanding ⁵	63.53M
Implied Shares Outstanding ⁶	63.53M
Float ⁸	62.83M
% Held by Insiders ¹	0.90%
% Held by Institutions ¹	104.32%
Shares Short (Oct 31, 2024) ⁴	4.13M
Short Ratio (Oct 31, 2024) ⁴	6.53
Short % of Float (Oct 31, 2024) ⁴	7.33%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	6.51%
Shares Short (prior month Sep 30, 2024) ⁴	3.53M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-29.48%
Operating Margin (ttm)	-38.21%

Management Effectiveness

Return on Assets (ttm)	-14.97%
Return on Equity (ttm)	-49.65%

Income Statement

Revenue (ttm)	434.42M
Revenue Per Share (ttm)	6.99
Quarterly Revenue Growth (yoy)	126.60%
Gross Profit (ttm)	N/A
EBITDA	-262.13M
Net Income Avi to Common (ttm)	-128.05M
Diluted EPS (ttm)	-2.09
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	734.17M
Total Cash Per Share (mrq)	11.56
Total Debt (mrq)	732.7M
Total Debt/Equity (mrq)	233.98%
Current Ratio (mrq)	3.32
Book Value Per Share (mrq)	4.93

Cash Flow Statement

Operating Cash Flow (ttm)	-242.15M
Levered Free Cash Flow (ttm)	-101.52M